// App-Quantinova.ai

: Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer

Researchers

Presenter

  • G. Gemenetzis

Principal Investigators

  • M. Nagai

  • V. Groot

  • D. Ding

  • A. Javed

  • R. Burkhart

  • E. Fishman

  • R. Hruban

  • M. Weiss

  • J. Cameron

  • A. Narang

  • D. Laheru

  • K. Lafaro

  • J. Herman

  • L. Zheng

  • W. Burns III

  • C. Wolfgang

  • J. He

Medical Centers

  • New York University, Surgery, New York, United States

  • Johns Hopkins University School of Medicine, Medicine/Hematology, Baltimore, United States

  • University Medical Center Utrecht, Utrecht, Netherlands

  • Northwell Health, Radiation Oncology, Manhasset, United States

  • Royal Infirmary of Edinburgh, Edinburgh, United Kingdom

  • Nara Medical University, Surgery, Nara, Japan

Locations

  • United States

  • United Kingdom

  • Netherlands

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreato-biliary malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final